Abstract
The aim of the study was to evaluate our institutional experience with monotherapies for hepatocellular carcinoma (HCC) in the setting of cirrhosis. A retrospective cohort study was carried out at the tertiary care academic referral center and involved 185 consecutive HCC patients with cirrhosis and no previous treatment who underwent resection (n = 61), transarterial chemoembolization (TACE) (n = 64), or liver transplantation (LT) (n = 60). Long-term survival and survival according to the Milan criteria were the main outcomes measured. Median survival after resection, TACE, and LT was 11, 14, and 23 months, respectively. Five-year cumulative survival after resection, TACE, and LT was 23, 10, and 59%, respectively (P = 0.001). Five-year cumulative disease-free survival after resection and LT was 15% and 77%, respectively (P = 0.002). The presence of complications in the resection group (P = 0.004), MELD score (P = 0.0003), and maximum tumor diameter (P = 0.05) in the TACE group, and tumor grade (P = 0.01) and complications (P = 0.004) in the LT group were found to be independent predictors of survival. Five-year survival for patients within the Milan criteria after resection, TACE, and LT was 26, 37, and 66%, respectively. Five-year survival for patients outside the Milan criteria for patients undergoing LT was 53%. The results suggest that LT represents the best oncological treatment option for patients with HCC in the setting of cirrhosis, even for those beyond the Milan criteria. Considering the scarcity of available organs, liver resection remains the best alternative option. TACE remains a potential therapy in patients within the Milan criteria, where it may be more beneficial than resection.
Similar content being viewed by others
Abbreviations
- AFP:
-
Alpha fetoprotein
- HBV:
-
Hepatitis B virus
- HCC:
-
Hepatocellular carcinoma
- HCV:
-
Hepatitis C virus
- LT:
-
Liver transplantation
- MELD:
-
Model for end-stage liver disease
- NS:
-
Not significant
- TACE:
-
Transarterial chemoembolization
- TNM:
-
Tumor Nodes Metastasis
- UICC:
-
Union International Contre le Cancer
References
Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127(suppl 1(5)):S5–S16. doi:10.1053/j.gastro.2004.09.011.
Parikh S, Hyman D. Hepatocellular cancer: a guide for the internist. Am J Med. 2007;120(3):194–202. doi:10.1016/j.amjmed.2006.11.020.
El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002;35(suppl 2(5)):S72–S78. doi:10.1097/00004836-200211002-00002.
Motola-Kuba D, Zamora-Valdés D, Uribe M, Méndez-Sánchez N. Hepatocellular carcinoma. An overview. Ann Hepatol. 2006;5(1):16–24.
Sotiropoulos GC, Malago M, Momenti E, Paul A, Nadalin S, Brokalaki E. Liver transplantation for hepatocellular carcinoma in cirrhosis: is clinical tumor classification before transplantation realistic? Transplantation. 2005;79(4):483–487. doi:10.1097/01.TP.0000152801.82734.74.
Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona EASL conference. European Association for the study of the liver. J Hepatol. 2001;35(3):421–430. doi:10.1016/S0168-8278(01)00130-1.
Llovet JM, Fuster J, Bruix J, Barcelona-Clínic Liver Cancer Group. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004;10(suppl 1(2)):S115–S120. doi:10.1002/lt.20034.
Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a western center. Ann Surg. 1999;229(6):790–799. doi:10.1097/00000658-199906000-00005.
Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 1993;218(2):145–151. doi:10.1097/00000658-199308000-00005.
Michel J, Suc B, Montpeyroux F, et al. Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol. 1997;26(6):1274–1280. doi:10.1016/S0168-8278(97)80462-X.
Otto G, Heuschen U, Hofmann WJ, Krumm G, Hinz U, Herfarth C. Survival and recurrence after liver transplantation versus liver resection for hepatocellular carcinoma: a retrospective analysis. Ann Surg. 1998;227(3):424–432. doi:10.1097/00000658-199803000-00015.
Huang YH, Wu JC, Chau GY, et al. Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients. Eur J Gastroenterol Hepatol. 1999;11(3):315–321. doi:10.1097/00042737-199903000-00017.
Figueras J, Jaurrieta E, Valls C, et al. Resection or transplantation for hepatocellular carcinoma in cirrhotic patients: outcomes based on indicated treatment strategy. J Am Coll Surg. 2000;190(5):580–587. doi:10.1016/S1072-7515(00)00251-9.
Lee HS, Kim KM, Yoon JH, et al. Therapeutic efficacy of transcatheter arterial chemoembolization as compared with hepatic resection in hepatocellular carcinoma patients with compensated liver function in a hepatitis B virus-endemic area: a prospective cohort study. J Clin Oncol. 2002;20(22):4459–4465. doi:10.1200/JCO.2002.02.013.
Bigourdan JM, Jaeck D, Meyer N, et al. Small hepatocellular carcinoma in child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl. 2003;9(5):513–520. doi:10.1053/jlts.2003.50070.
Tang ZY, Zhou XD, Ma ZC, et al. Downstaging followed by resection plays a role in improving prognosis of unresectable hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int. 2004;3(4):495–498.
Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R Jr, Kerlan R. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transplant. 2005;5(4 Pt1):795–804. doi:10.1111/j.1600-6143.2005.00750.x.
Sotiropoulos GC, Malago M, Molmenti E, et al. Efficacy of transarterial chemoembolization prior to liver transplantation for hepatocellular carcinoma as found in pathology. Hepatogastroenterology. 2005;52(62):329–332.
Majno PE, Sarasin FP, Mentha G, Hadengue A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology. 2000;31(4):899–906. doi:10.1053/he.2000.5763.
Adam R, Azoulay D, Castaing D, et al. Liver resection as a bridge to transplantation for hepatocellular carcinoma on cirrhosis: a reasonable strategy? Ann Surg. 2003;238(4):508–518.
Belghiti J, Cortes A, Abdalla EK, et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg. 2003;238(6):885–892. doi:10.1097/01.sla.0000098621.74851.65.
Takano S, Watanabe Y, Ohishi H, et al. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series. Eur J Surg Oncol. 2000;26(1):67–72. doi:10.1053/ejso.1999.0743.
Christians KK, Pitt HA, Rilling WS, et al. Hepatocellular carcinoma: multimodality management. Surgery. 2001;130(4):554–559. doi:10.1067/msy.2001.117106.
Medina-Franco H, Sellers MT, Eckhoff DE, Bynon JS, Urist MM, Heslin MJ. Multimodality treatment for patients with hepatocellular carcinoma: analysis of prognostic factors in a single Western institution series. J Gastrointest Surg. 2001;5(6):638–645. doi:10.1016/S1091-255X(01)80107-4.
Sotiropoulos GC, Lang H, Frilling A, et al. Resectability of hepatocellular carcinoma: evaluation of 333 consecutive cases at a single hepatobiliary specialty center and systematic review of the literature. Hepatogastroenterology. 2006;53(69):322–329.
Dharancy S, Boitard J, Decaens T, et al. Comparison of two techniques of transarterial chemoembolization before liver transplantation for hepatocellular carcinoma: a case-control study. Liver Transpl. 2007;13(5):665–671. doi:10.1002/lt.21109.
Yuen MF, Chan AO, Wong BC, et al. Transarterial chemoembolization for inoperable, early stage hepatocellular carcinoma in patients with Child-Pugh grade A and B: results of a comparative study in 96 Chinese patients. Am J Gastroenterol. 2003;98(5):1181–1185.
Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334(11):693–699. doi:10.1056/NEJM199603143341104.
Malago M, Sotiropoulos GC, Nadalin S, et al. Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report. Liver Transpl. 2006;12(6):934–940. doi:10.1002/lt.20677.
De Carlis L, Giacomoni A, Lauterio A, et al. Liver transplantation for hepatocellular cancer: should the current indication criteria be changed? Transpl Int. 2003;16(2):115–122. doi:10.1111/j.1432-2277.2003.tb00272.x.
Broelsch CE, Frilling A, Malago M. Should we expand the criteria for liver transplantation for hepatocellular carcinoma—yes of course!. J Hepatol. 2005;43(4):569–573. doi:10.1016/j.jhep.2005.07.016.
Hiatt JR, Carmody IC, Busuttil RW. Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?—no, never. J Hepatol. 2005;43(4):573–577. doi:10.1016/j.jhep.2005.07.017.
Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33(6):1394–1403. doi:10.1053/jhep.2001.24563.
Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: Implications for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11(9):1086–1092. doi:10.1002/lt.20472.
Sasaki Y, Imaoka S, Nakano H, et al. Indications for hepatectomy for hepatocellular carcinoma—what stage of the disease is the best indication for surgery? J Hepatobiliary Pancreat Surg. 1998;5(1):14–17. doi:10.1007/PL00009944.
Sotiropoulos GC, Lang H, Nadalin S, et al. Liver transplantation for hepatocellular carcinoma: University Hospital Essen experience and metaanalysis of prognostic factors. J Am Coll Surg. 2007;205(5):661–675. doi:10.1016/j.jamcollsurg.2007.05.023.
Sotiropoulos GC, Malagó M, Molmenti EP, et al. Hilar lymph nodes sampling at the time of liver transplantation for hepatocellular carcinoma: to do or not to do? Meta-analysis to determine the impact of hilar lymph nodes metastases on tumor recurrence and survival in patients with hepatocellular carcinoma undergoing liver transplantation. Transpl Int. 2007;20(2):141–146. doi:10.1111/j.1432-2277.2006.00412.x.
Lai EC, Fan ST, Lo CM, Chu KM, Liu CL, Wong J. Hepatic resection for hepatocellular carcinoma: an audit of 343 patients. Ann Surg. 1995;221(3):291–298. doi:10.1097/00000658-199503000-00012.
Lang BH, Poon RT, Fan ST, Wong J. Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis. Arch Surg. 2003;138(11):1207–1213. doi:10.1001/archsurg.138.11.1207.
Hanazaki K, Kajikawa S, Shimozawa N, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg. 2000;191(4):381–388. doi:10.1016/S1072-7515(00)00700-6.
Takayasu K, Arii S, Ikai I, et al. Liver Cancer Study Group of Japan. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 2006;131(2):461–469. doi:10.1053/j.gastro.2006.05.021.
Biselli M, Andreone P, Gramenzi A, et al. Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study. Clin Gastroenterol Hepatol. 2005;3(9):918–925. doi:10.1016/S1542-3565(05)00425-8.
Molinari M, Kachura JR, Dixon E, et al. Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre. Clin Oncol. 2006;18(9):684–692. doi:10.1016/j.clon.2006.07.012.
Hemming AW, Cattral MS, Reed AI, Van Der Werf WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann Surg. 2001;233(5):652–659. doi:10.1097/00000658-200105000-00009.
Molmenti EP, Klintmalm GB. Liver transplantation in association with hepatocellular carcinoma: an update of the International Tumor Registry. Liver Transpl. 2002;8(9):736–748. doi:10.1053/jlts.2002.34879.
De Carlis L, Giacomoni A, Pirotta V, et al. Surgical treatment of hepatocellular cancer in the era of hepatic transplantation. J Am Coll Surg. 2003;196(6):887–897. doi:10.1016/S1072-7515(03)00140-6.
Leung JY, Zhu AX, Gordon FD, et al. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl. 2004;10(11):1343–1354. doi:10.1002/lt.20311.
Salizzoni M, Zamboni F, Lupo F, Franchello A, David E, Rizzetto M. Liver transplantation for early-detected, multifocal hepatocellular carcinoma. Br J Surg. 2001;88(9):1194–1195. doi:10.1046/j.0007-1323.2001.01844.x.
Wong LL, Tsai N, Limm W, Wong L. Liver transplant for hepatocellular cancer: a treatment for the select few. Clin Transplant. 2004;18(2):205–210. doi:10.1046/j.1399-0012.2003.00157.x.
Lang H, Sotiropoulos GC, Brokalaki EI, et al. Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers. J Am Coll Surg. 2007;205(1):27–36. doi:10.1016/j.jamcollsurg.2007.03.002.
Laurent C, Blanc JF, Nobili S, et al. Prognostic factors and longterm survival after hepatic resection for hepatocellular carcinoma originating from noncirrhotic liver. J Am Coll Surg. 2005;201(5):656–662. doi:10.1016/j.jamcollsurg.2005.05.027.
Dupont-Bierre E, Compagnon P, Raoul JL, Fayet G, de Lajarte-Thirouard AS, Boudjema K. Resection of hepatocellular carcinoma in noncirrhotic liver: analysis of risk factors for survival. J Am Coll Surg. 2005;201(5):663–670. doi:10.1016/j.jamcollsurg.2005.06.265.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sotiropoulos, G.C., Drühe, N., Sgourakis, G. et al. Liver Transplantation, Liver Resection, and Transarterial Chemoembolization for Hepatocellular Carcinoma in Cirrhosis: Which Is the Best Oncological Approach?. Dig Dis Sci 54, 2264–2273 (2009). https://doi.org/10.1007/s10620-008-0604-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-008-0604-4